Immuneering (IMRX) Return on Assets (2021 - 2026)

Immuneering's Return on Assets history runs 6 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Assets rose 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, up 1.0% from the prior year.
• Return on Assets fell to 0.0% in Q1 2026 per IMRX's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.02% in Q2 2025.
• The 5-year median for Return on Assets is 0.01% (2022), against an average of 0.01%.
• Biggest YoY gain for Return on Assets was 1 bps in 2025; the steepest drop was 1 bps in 2025.
• Year by year, Return on Assets stood at 0.01% in 2022, then slipped by 19 bps to 0.01% in 2023, then slumped by 47 bps to 0.01% in 2024, then soared by 68 bps to 0.0% in 2025, then decreased by 25 bps to 0.0% in 2026.
• Per Business Quant, the three latest IMRX Return on Assets figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).